Maky Zanganeh, Director at Pulse Biosciences, Inc. (PLSE), bought 15,700 shares at $12.12 ($190K) on 2017-02-14, disclosed to the SEC on 2018-03-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.12 | 9,500 | $115K | 60.5% |
| 2 | $12.15 | 6,200 | $75K | 39.5% |
| Total | $12.13 avg | 15,700 | $190K | 100% |
| Filing → |
| PLSE | BUY | 2020-06-25 | $13K | — | Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2017-12-15 | $26K | — | Filing → |